Your browser is out-of-date!

Update your browser to view this website correctly.

1Cookies

2Disclaimer

Current market commentary with Dr. Daniel Koller, Head Investment Management Team BB Biotech at Bellevue Asset Management.

BB Biotech: «Cancer medicine improves the chances of a cure»

Current market commentary with Dr. Daniel Koller, Head Investment Management Team BB Biotech at Bellevue Asset Management.
09.12.2021 - Daniel Koller